| FDA's FY 2019 Justification: How Extra Funds Will be Used
As discussed earlier, FDA's Office of Regulatory Affairs is also looking to establish a “Center of Excellence on Compounding for Outsourcing Facilities,” to provide education and training, conduct research to help inform regulatory decision-making, and implement programs to harmonize and strengthen ...
|
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Tuesday, April 3, 2018
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment